Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study

被引:35
作者
Yang, Xin [1 ]
Leslie, Goska [1 ]
Gentry-Maharaj, Aleksandra [2 ]
Ryan, Andy [2 ]
Intermaggio, Maria [3 ]
Lee, Andrew [1 ]
Kalsi, Jatinderpal K. [2 ]
Tyrer, Jonathan [4 ]
Gaba, Faiza [5 ]
Manchanda, Ranjit [2 ,5 ,6 ]
Pharoah, Paul D. P. [1 ,4 ]
Gayther, Simon A. [7 ,8 ]
Ramus, Susan J. [3 ,9 ]
Jacobs, Ian [2 ,10 ,11 ]
Menon, Usha [2 ]
Antoniou, Antonis C. [1 ]
机构
[1] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England
[2] UCL, Inst Womens Hlth, Dept Womens Canc, London, England
[3] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia
[4] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England
[5] Queen Mary Univ London, Barts Canc Inst, Ctr Expt Canc Med, London, England
[6] Barts Hlth NHS Trust, Royal London Hosp, Dept Gynaecol Oncol, London, England
[7] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA
[8] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA
[9] Garvan Inst Med Res, Kinghorn Canc Ctr, Sydney, NSW, Australia
[10] Univ New South Wales, Sydney, NSW, Australia
[11] Univ Manchester, Manchester, Lancs, England
基金
英国医学研究理事会;
关键词
SUSCEPTIBILITY LOCI; PROSTATE-CANCER; IDENTIFICATION; ASSOCIATION; UKCTOCS; ALLELES; BREAST; BRCA2;
D O I
10.1136/jmedgenet-2018-105313
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Genome-wide association studies have identified >30 common SNPs associated with epithelial ovarian cancer (EOC). We evaluated the combined effects of EOC susceptibility SNPs on predicting EOC risk in an independent prospective cohort study. Methods We genotyped ovarian cancer susceptibility single nucleotide polymorphisms (SNPs) in a nested case-control study (750 cases and 1428 controls) from the UK Collaborative Trial of Ovarian Cancer Screening trial. Polygenic risk scores (PRSs) were constructed and their associations with EOC risk were evaluated using logistic regression. The absolute risk of developing ovarian cancer by PRS percentiles was calculated. Results The association between serous PRS and serous EOC (OR 1.43, 95% CI 1.29 to 1.58, p=1.3x10(-11)) was stronger than the association between overall PRS and overall EOC risk (OR 1.32, 95% CI 1.21 to 1.45, p=5.4x10(-10)). Women in the top fifth percentile of the PRS had a 3.4-fold increased EOC risk compared with women in the bottom 5% of the PRS, with the absolute EOC risk by age 80 being 2.9% and 0.9%, respectively, for the two groups of women in the population. Conclusion PRSs can be used to predict future risk of developing ovarian cancer for women in the general population. Incorporation of PRSs into risk prediction models for EOC could inform clinical decision-making and health management.
引用
收藏
页码:546 / 554
页数:9
相关论文
共 50 条
  • [41] Towards clinical utility of polygenic risk scores
    Lambert, Samuel A.
    Abraham, Gad
    Inouye, Michael
    HUMAN MOLECULAR GENETICS, 2019, 28 (R2) : R133 - R142
  • [42] Polygenic Risk Score for Early Prediction of Sepsis Risk in the Polytrauma Screening Cohort
    Lu, Hongxiang
    Wen, Dalin
    Sun, Jianhui
    Du, Juan
    Qiao, Liang
    Zhang, Huacai
    Zeng, Ling
    Zhang, Lianyang
    Jiang, Jianxin
    Zhang, Anqiang
    FRONTIERS IN GENETICS, 2020, 11
  • [43] Metabolomic profiles, polygenic risk scores and risk of rheumatoid arthritis: a population-based cohort study in the UK Biobank
    Fang, Xin-Yu
    Zhang, Jie
    Qian, Ting-Ting
    Gao, Peng
    Wu, Qing
    Fang, Quan
    Ke, Su-Su
    Huang, Rong-Gui
    Zhang, Heng-Chuan
    Qiao, Ni-Ni
    Fan, Yin-Guang
    Ye, Dong-Qing
    RMD OPEN, 2023, 9 (04):
  • [44] Polygenic risk scores, radiation treatment exposures and subsequent cancer risk in childhood cancer survivors
    Gibson, Todd M.
    Karyadi, Danielle M.
    Hartley, Stephen W.
    Arnold, Michael A.
    de Gonzalez, Amy Berrington
    Conces, Miriam R.
    Howell, Rebecca M.
    Kapoor, Vidushi
    Leisenring, Wendy M.
    Neglia, Joseph P.
    Sampson, Joshua N.
    Turcotte, Lucie M.
    Chanock, Stephen J.
    Armstrong, Gregory T.
    Morton, Lindsay M.
    NATURE MEDICINE, 2024, 30 (04) : 690 - 698
  • [45] No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity
    Barnett, Gillian C.
    Kerns, Sarah L.
    Dorling, Leila
    Fachal, Laura
    Aguado-Barrera, Miguel E.
    Martinez-Calvo, Laura
    Jandu, Harkeran K.
    Welsh, Ceilidh
    Tyrer, Jonathan
    Coles, Charlotte E.
    Haviland, Joanne S.
    Parker, Christopher
    Gomez-Caamano, Antonio
    Calvo-Crespo, Patricia
    Sosa-Fajardo, Paloma
    Burnet, Neil G.
    Summersgill, Holly
    Webb, Adam
    De Ruysscher, Dirk
    Seibold, Petra
    Chang-Claude, Jenny
    Talbot, Christopher J.
    Rattay, Tim
    Parliament, Matthew
    De Ruyck, Kim
    Rosenstein, Barry S.
    Pharoah, Paul D. P.
    Dunning, Alison M.
    Vega, Ana
    West, Catharine M. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : 494 - 501
  • [46] Prospective study of physical activity and the risk of ovarian cancer
    Leitzmann, Michael F.
    Koebnick, Corinna
    Moore, Steven C.
    Danforth, Kim N.
    Brinton, Louise A.
    Hollenbeck, Albert R.
    Schatzkin, Arthur
    Lacey, James V.
    CANCER CAUSES & CONTROL, 2009, 20 (05) : 765 - 773
  • [47] Clinical Impact of Polygenic Risk Score for Breast Cancer Risk Prediction in 382 Individuals with Hereditary Breast and Ovarian Cancer Syndrome
    Stiller, Sarah
    Drukewitz, Stephan
    Lehmann, Kathleen
    Hentschel, Julia
    Strehlow, Vincent
    CANCERS, 2023, 15 (15)
  • [48] Genetic risk factors for ovarian cancer and their role for endometriosis risk
    Burghaus, Stefanie
    Fasching, Peter A.
    Haeberle, Lothar
    Ruebner, Matthias
    Buechner, Kathrin
    Blum, Simon
    Engel, Anne
    Ekici, Arif B.
    Hartmann, Arndt
    Hein, Alexander
    Beckmann, Matthias W.
    Renner, Stefan P.
    GYNECOLOGIC ONCOLOGY, 2017, 145 (01) : 142 - 147
  • [49] How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis
    Siltari, Aino
    Lonnerbro, Ragnar
    Pang, Karl
    Shiranov, Kirill
    Asiimwe, Alex
    Evans-Axelsson, Susan
    Franks, Billy
    Kiran, Amit
    Murtola, Teemu J.
    Schalken, Jack
    Steinbeisser, Carl
    Bjartell, Anders
    PIONEER Consortium
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 316e1 - 316e11
  • [50] Implementing polygenic risk scores in the clinic
    Vogan, Kyle
    NATURE GENETICS, 2024, 56 (04) : 557 - 557